47
Participants
Start Date
December 9, 2023
Primary Completion Date
March 20, 2025
Study Completion Date
April 27, 2025
STSA-1002 Injection Placebo
Intravenous infusion
STSA-1002 Injection
Intravenous infusion
China-Japan Friendship Hospital, Beijing
Beijing Luhe Hospital affiliated to Capital Medical University, Beijing
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Zhongda Hospital affiliated to Southeast University, Nanjing
The First Affiliated Hospital of Soochow University, Suzhou
The First Affiliated Hospital of Bengbu Medical University, Bengbu
Qilu Hospital of Shandong University, Jinan
Jinan Central Hospital, Jinan
Zibo Municipal Hospital, Zibo
Qingdao Municipal Hospital, Qingdao
Hangzhou Red Cross Hospital, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
The First Affiliated Hospital of Nanchang University, Nanchang
The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University, Chongqing
Xiangtan Central Hospital, Xiangtan
Wuhan Jinyintan Hospital, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
Huaihe Hospital of Henan University, Kaifeng
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Xinxiang Medical College, Xingxiang
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
Kaifeng Central Hospital, Kaifeng
Peking University Shenzhen Hospital, Shenzhen
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
Sichuan Provincial People's Hospital, Chengdu
The First Affiliated Hospital of Chengdu Medical College, Chengdu
Chengdu Fifth People's Hospital, Chengdu
The First Affiliated Hospital of Xi 'an Jiaotong University, Xi’an
The Second Hospital of Hebei Medical University City:Shijiazhuang, Shijiazhuang
Shanxi Bethune Hospital, Taiyuan
Staidson (Beijing) Biopharmaceuticals Co., Ltd
INDUSTRY